Literature DB >> 21400557

Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects.

Sven Haufe1, Stefan Engeli, Petra Kast, Jana Böhnke, Wolfgang Utz, Verena Haas, Mario Hermsdorf, Anja Mähler, Susanne Wiesner, Andreas L Birkenfeld, Henrike Sell, Christoph Otto, Heidrun Mehling, Friedrich C Luft, Juergen Eckel, Jeanette Schulz-Menger, Michael Boschmann, Jens Jordan.   

Abstract

UNLABELLED: Obesity-related hepatic steatosis is a major risk factor for metabolic and cardiovascular disease. Fat reduced hypocaloric diets are able to relieve the liver from ectopically stored lipids. We hypothesized that the widely used low carbohydrate hypocaloric diets are similarly effective in this regard. A total of 170 overweight and obese, otherwise healthy subjects were randomized to either reduced carbohydrate (n = 84) or reduced fat (n = 86), total energy restricted diet (-30% of energy intake before diet) for 6 months. Body composition was estimated by bioimpedance analyses and abdominal fat distribution by magnetic resonance tomography. Subjects were also submitted to fat spectroscopy of liver and oral glucose tolerance testing. In all, 102 subjects completed the diet intervention with measurements of intrahepatic lipid content. Both hypocaloric diets decreased body weight, total body fat, visceral fat, and intrahepatic lipid content. Subjects with high baseline intrahepatic lipids (>5.56%) lost ≈7-fold more intrahepatic lipids compared with those with low baseline values (<5.56%) irrespective of diet composition. In contrast, changes in visceral fat mass and insulin sensitivity were similar between subgroups, with low and high baseline intrahepatic lipids.
CONCLUSION: A prolonged hypocaloric diet low in carbohydrates and high in fat has the same beneficial effects on intrahepatic lipid accumulation as the traditional low-fat hypocaloric diet. The decrease in intrahepatic lipids appears to be independent of visceral fat loss and is not tightly coupled with changes in whole body insulin sensitivity during 6 months of an energy restricted diet.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21400557     DOI: 10.1002/hep.24242

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  95 in total

1.  Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.

Authors:  B G P Koot; O H van der Baan-Slootweg; S Vinke; A E Bohte; C L J Tamminga-Smeulders; P L M Jansen; J Stoker; M A Benninga
Journal:  Int J Obes (Lond)       Date:  2015-08-28       Impact factor: 5.095

Review 2.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 3.  Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

Authors:  William N Hannah; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2016-05       Impact factor: 3.199

Review 4.  Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.

Authors:  Metin Basaranoglu; Gokcen Basaranoglu; Elisabetta Bugianesi
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

5.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

6.  Increased catabolic state in spinocerebellar ataxia type 1 patients.

Authors:  Anja Mähler; Jochen Steiniger; Matthias Endres; Friedemann Paul; Michael Boschmann; Sarah Doss
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 7.  Effects of dietary macronutrients on liver fat content in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Esther Winters-van Eekelen; Inge Verkouter; Harry P F Peters; Marjan Alssema; Babette G de Roos; Vera B Schrauwen-Hinderling; Kay H M Roumans; Jan W Schoones; Peter L Zock; Patrick Schrauwen; Frits R Rosendaal; Olaf M Dekkers; Renée de Mutsert
Journal:  Eur J Clin Nutr       Date:  2020-10-22       Impact factor: 4.016

Review 8.  Nonalcoholic fatty liver disease: implications for cardiovascular risk.

Authors:  Amreen Dinani; Arun Sanyal
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

Review 9.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

10.  A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children.

Authors:  Marta Ramon-Krauel; Sandra L Salsberg; Cara B Ebbeling; Stephan D Voss; Robert V Mulkern; Margaret M Apura; Emily A Cooke; Karen Sarao; Maureen M Jonas; David S Ludwig
Journal:  Child Obes       Date:  2013-05-24       Impact factor: 2.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.